246 related articles for article (PubMed ID: 19801992)
1. Engineering splicing factors with designed specificities.
Wang Y; Cheong CG; Hall TM; Wang Z
Nat Methods; 2009 Nov; 6(11):825-30. PubMed ID: 19801992
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
3. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
Dou Z; Lei H; Su W; Zhang T; Chen X; Yu B; Zhen X; Si J; Sun C; Zhang H; Di C
Cell Death Dis; 2024 Feb; 15(2):160. PubMed ID: 38383492
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
5. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
[TBL] [Abstract][Full Text] [Related]
6. Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.
Michelle L; Cloutier A; Toutant J; Shkreta L; Thibault P; Durand M; Garneau D; Gendron D; Lapointe E; Couture S; Le Hir H; Klinck R; Elela SA; Prinos P; Chabot B
Mol Cell Biol; 2012 Mar; 32(5):954-67. PubMed ID: 22203037
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
[TBL] [Abstract][Full Text] [Related]
8. Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.
Wilusz JE; Devanney SC; Caputi M
Nucleic Acids Res; 2005; 33(20):6547-54. PubMed ID: 16299354
[TBL] [Abstract][Full Text] [Related]
9. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
Massiello A; Roesser JR; Chalfant CE
FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.
DeOcesano-Pereira C; Amaral MS; Parreira KS; Ayupe AC; Jacysyn JF; Amarante-Mendes GP; Reis EM; Verjovski-Almeida S
Nucleic Acids Res; 2014 Jul; 42(13):8343-55. PubMed ID: 24992962
[TBL] [Abstract][Full Text] [Related]
11. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.
Zhou A; Ou AC; Cho A; Benz EJ; Huang SC
Mol Cell Biol; 2008 Oct; 28(19):5924-36. PubMed ID: 18663000
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
Le Sénéchal R; Keruzoré M; Quillévéré A; Loaëc N; Dinh VT; Reznichenko O; Guixens-Gallardo P; Corcos L; Teulade-Fichou MP; Granzhan A; Blondel M
Nucleic Acids Res; 2023 Nov; 51(20):11239-11257. PubMed ID: 37811881
[TBL] [Abstract][Full Text] [Related]
13. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes.
Shkreta L; Froehlich U; Paquet ER; Toutant J; Elela SA; Chabot B
Mol Cancer Ther; 2008 Jun; 7(6):1398-409. PubMed ID: 18566212
[TBL] [Abstract][Full Text] [Related]
14. Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells.
Wei HH; Liu Y; Wang Y; Lu Q; Yang X; Li J; Wang Z
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28518098
[TBL] [Abstract][Full Text] [Related]
15. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition.
Izquierdo JM
J Biol Chem; 2008 Jul; 283(27):19077-84. PubMed ID: 18463097
[TBL] [Abstract][Full Text] [Related]
16. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
Mercatante DR; Bortner CD; Cidlowski JA; Kole R
J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
[TBL] [Abstract][Full Text] [Related]
17. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
18. Modification of alternative splicing of Bcl-x pre-mRNA in bladder cancer cells.
Zhu Z; Xing S; Cheng P; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):213-6. PubMed ID: 16850750
[TBL] [Abstract][Full Text] [Related]
19. TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.
Montes M; Cloutier A; Sánchez-Hernández N; Michelle L; Lemieux B; Blanchette M; Hernández-Munain C; Chabot B; Suñé C
Mol Cell Biol; 2012 Feb; 32(4):751-62. PubMed ID: 22158966
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.
Bielli P; Busà R; Di Stasi SM; Munoz MJ; Botti F; Kornblihtt AR; Sette C
EMBO Rep; 2014 Apr; 15(4):419-27. PubMed ID: 24514149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
